CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) “__________” BETWEENTrial Agreement • April 15th, 2024
Contract Type FiledApril 15th, 2024Istituto clinico Humanitas – Humanitas Mirasole S.p.A. shareholder company (hereinafter the “Entity”), headquartered in Rozzano (Milan) Zip code 20089, Via Alessandro Manzoni 56, Tax Code 10125410158, VAT no. 10982360967 , through its Legal Representative Mr. Luciano Ravera , in his capacity as managing director with the powers to enter into this agreement
INDEPENDENT CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) BETWEENTrial Agreement • November 21st, 2022
Contract Type FiledNovember 21st, 2022Fondazione IRCCS San Gerardo dei Tintori (hereinafter the “Entity"), headquartered in via Pergolesi 33, 20900 Monza (MB), tax code and VAT no. 12698710964, through its Legal Representative Dr. Claudio Cogliati in his capacity of President of the Board of Directors who, by resolution n° 17 of 27.03.2023, delegates the signing of this contract to the General Director, Dr. Silvano Casazza
INDEPENDENT CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) BETWEENTrial Agreement • November 21st, 2022
Contract Type FiledNovember 21st, 2022Fondazione IRCCS San Gerardo dei Tintori (hereinafter the “Entity"), headquartered in via Pergolesi 33, 20900 Monza (MB), tax code and VAT no. 12698710964, through its Legal Representative Dr. Claudio Cogliati in the capacity of President of the Board of Directors
CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) “__________” BETWEENTrial Agreement • November 4th, 2022
Contract Type FiledNovember 4th, 2022_________ (indicate name of Healthcare Facility) (hereinafter the “Entity”), headquartered in _______, Tax Code and VAT no. _________, through its Legal Representative _________, in her/his capacity as _________ (indicate whether Director General, CEO, Extraordinary Commissioner, etc.) (if applicable: who granted Ms./Mr. _________ (name and position of signatory) with the powers to enter into this agreement